Understanding the pharmacokinetic (PK) properties of MPI tracers is necessary for enabling the wide spectrum of possible in vivo MPI applications. For intravenously administered tracers, blood half-life (t 1/2 ) is a critical PK property that will help determine the suitability and clinical readiness for applications such as cardiovascular and molecular imaging. Here we show the ability to tune the in vivo circulation characteristics (t 1/2 ) of polyethylene glycol (PEG)-coated ("PEGylated") MPI tracers. PEG is a biocompatible polymer frequently used to enhance the circulation characteristics of nanoparticles and other macromolecules such as antibodies.
. Properties of MPI tracers used to evaluate blood half-life in female CD-1 mice Figure 1 . Blood half-life of PEGylated MPI tracers. For each averaged data point, n = 3. Blood half-life determined using single-compartment PK model:
; where R is the elimination rate constant obtained from the fitting curves.
